<![CDATA[How has Immunotherapy Evolved in Breast Cancer Treatment?]]>
Historically, breast cancer was categorized as a "cold" malignancy—characterized by a low tumor mutational burden and a sparse immune microenvironment that offered little hope for early immunotherapy interventions. However, the treatment …